| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Robby Markwart | Q86409838 |
| Niklas Willrich | Q87632964 | ||
| Olaniyi Ayobami | Q91727765 | ||
| Iruka N. Okeke | Q42412314 | ||
| P2093 | author name string | Tim Eckmanns | |
| Thomas Harder | |||
| P2860 | cites work | Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries | Q26827160 |
| The spread of carbapenemase-producing bacteria in Africa: a systematic review | Q27000635 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860606 | ||
| National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. | Q30977541 | ||
| Prevalence of nosocomial infections and anti-infective therapy in Benin: results of the first nationwide survey in 2012 | Q33688083 | ||
| Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis | Q34154098 | ||
| Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections | Q34168292 | ||
| Multistate point-prevalence survey of health care-associated infections | Q34412128 | ||
| Gram-negative infections in adult intensive care units of latin america and the Caribbean | Q34695842 | ||
| Epidemiological monitoring of nosocomial infections caused by acinetobacter baumannii | Q35039125 | ||
| High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update. | Q35843094 | ||
| Prevalence and epidemiological characteristics of congenital cataract: a systematic review and meta-analysis. | Q36059332 | ||
| The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
| Acinetobacter infection | Q37114411 | ||
| Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options | Q37960325 | ||
| Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement | Q38022351 | ||
| The Burden of Healthcare-Associated Infections in Southeast Asia: A Systematic Literature Review and Meta-analysis | Q38353616 | ||
| A point-prevalence survey of healthcare-associated infection in fifty-two Chinese hospitals | Q39071151 | ||
| Cost analysis and evaluation of nosocomial infections in intensive care units | Q39102882 | ||
| Hospital-wide comparison of health care-associated infection among 8 intensive care units: A retrospective analysis for 2010-2015. | Q39180249 | ||
| Nosocomial infections due to Acinetobacter baumannii in a neurosurgery ICU. | Q51192014 | ||
| Local resistance patterns to antimicrobials in internal medicine: a focused report from the REGIMEN (REGistro Infezioni in MEdicina INterna) study. | Q53120107 | ||
| Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study. | Q53684049 | ||
| Incidence of Multidrug-Resistant Organism Among Children Admitted to Pediatric Intensive Care Unit in a Developing Country. | Q53697796 | ||
| First report of colistin resistance among carbapenem-resistant isolates recovered from hospitalized patients in Egypt | Q57167678 | ||
| Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study | Q58553176 | ||
| Hospital-Wide Surveillance of Healthcare-Associated Infections as a Source of Information about Specific Hospital Needs. A 5-Year Observation in a Multiprofile Provincial Hospital in the South of Poland | Q58758308 | ||
| Emergence of high drug resistant bacterial isolates from patients with health care associated infections at Jimma University medical center: a cross sectional study | Q59336637 | ||
| A Systematic Review of the Burden of Multidrug-Resistant Healthcare-Associated Infections Among Intensive Care Unit Patients in Southeast Asia: The Rise of Multidrug-Resistant Acinetobacter baumannii | Q88178597 | ||
| National prevalence estimates for resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States | Q92960092 | ||
| Phenotypic characterization of Acinetobacter baumannii isolates from intensive care units at a tertiary-care hospital in Egypt | Q39290359 | ||
| ICU Pathogens: A Continuous Challenge. | Q39508775 | ||
| CDC definitions for nosocomial infections, 1988 | Q39605670 | ||
| The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province, China | Q40083502 | ||
| The analysis of the occurrence of nosocomial infections in the neurosurgical ward in the District Hospital from 2003-2012. | Q40372149 | ||
| Healthcare-associated infections in a newly opened pediatric intensive care unit in Turkey: Results of four-year surveillance. | Q40734412 | ||
| Antibiotic consumption and resistance: results of the SPIN-UTI project of the GISIO-SItI. | Q40938006 | ||
| Mortality risk factors in burn care units considering the clinical significance of acinetobacter infections | Q41424763 | ||
| Three-year study of health care-associated infections in a Turkish pediatric ward | Q41666311 | ||
| Nosocomial infection characteristics in a burn intensive care unit: analysis of an eleven-year active surveillance. | Q42238422 | ||
| Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece | Q42688113 | ||
| Global spread of carbapenem-resistant Acinetobacter baumannii | Q43227337 | ||
| Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). | Q43364380 | ||
| CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting | Q43758287 | ||
| International study of the prevalence and outcomes of infection in intensive care units | Q44988294 | ||
| The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee | Q45265404 | ||
| Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. | Q45933628 | ||
| A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids | Q46252843 | ||
| Epidemiology and microbiological profile comparison between community and hospital acquired infections: A multicenter retrospective study in Lebanon. | Q46296774 | ||
| Intensive care unit-acquired Acinetobacter baumannii infections in a Moroccan teaching hospital: epidemiology, risk factors and outcome | Q47138987 | ||
| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. | Q47765000 | ||
| Risk factors for health care-associated infection in hospitalized adults: Systematic review and meta-analysis | Q47796029 | ||
| Incidence, Microbiological Profile and Risk Factors of Healthcare-Associated Infections in Intensive Care Units: A 10 Year Observation in a Provincial Hospital in Southern Poland | Q49434440 | ||
| Classifying antibiotics in the WHO Essential Medicines List for optimal use-be AWaRe | Q50174236 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | Acinetobacter baumannii | Q3241189 |
| P304 | page(s) | 1747-1759 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Emerging Microbes & Infections | Q27724513 |
| P1476 | title | The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis | |
| P478 | volume | 8 |
| Q90463890 | L-lysine potentiates aminoglycosides against Acinetobacter baumannii via regulation of proton motive force and antibiotics uptake | cites work | P2860 |
Search more.